ALLAN SNYDER: Open Payments
NPI 1477585099 · TAMARAC, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 13 payments from 11 companies in 2025. Trend: 2023 $1,829 · 2024 $1,984 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $111 |
| GENZYME CORPORATION | 2 | $79 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Organon LLC | 1 | $31 |
| ABBVIE INC. | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $21 |
| UCB, Inc. | 1 | $19 |
| Incyte Corporation | 1 | $19 |
Products named: DUPIXENT, RINVOQ, Rhapsido, Zoryve, TREMFYA, Bimzelx, OPZELURA, ZELSUVMI.
Industry payments across FL — which companies pay providers there.
